CAS opens Shanghai Institute of Biotechnology Industrial Park in Ningbo, Zhejiang Province

The center will be focused on new drug developments and manufacturing, using the competences of the Ningbo Institute of Drug Research as a core function. In addition, development of novel medical equipment will be of central interest. Total investments are planned at 4.85 billion yuan (650 million €).

China Bio news release, May 24, 2017

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year. Accept or Deny